https://apnews.com/cb05536ddf7e4546e8f0a38a0b0fcb64

PORTO, Portugal (AP) — European Union leaders said Friday that the most pressing impediments to COVID-19 vaccine supplies are not intellectual property rights but export bans and production capacity issues that need to be addressed before patent waivers should be considered.

In the wake of the United States backing calls to waive patents on vaccine technology, French President Emmanuel Macron summarized the view from Europe when he said on the sidelines of an EU summit, “You can give the intellectual property to laboratories that do not know how to produce it. They won’t produce it tomorrow.”